Synthesis and anticonvulsant activity of 7-Alkoxy-Triazolo-[3, 4-b] Benzo[d]Thiazoles

Medicinal Chemistry

Volumn 6, Issue 5, 2010, Pages 313-320

  Deng, Xian Qing ^a   Song, Ming Xia ^a   Wei, Cheng Xi ^a   Li, Fu Nan ^b   Quan, Zhe Shan ^a  

^a YANBIAN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Anticonvulsant; Benzo d thiazoles; Maximal electroshock; Synthesis; Triazole

Indexed keywords

7 (2 BROMOBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 (2 CHLOROBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 (2 FLUOROBENZYLOXY)TRIAZOLO [3,4 B]BENZO[D]THIAZOLE; 7 (3 BROMOBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 (3 CHLOROBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 (3 FLUOROBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 (4 BROMOBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 (4 CHLOROBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 (4 FLUOROBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 (4 METHOXYBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 (4 METHYLBENZYLOXY)TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 ALKOXY TRIAZOLO[3,4 B]BENZO[D]THIAZOLE DERIVATIVE; 7 BENZYLOXY TRIAZOLO [3, 4 B]BENZO[D]THIAZOLE; 7 BUTOXY TRIAZOLO [3,4 B]BENZO[D]THIAZOLE; 7 DECYLOXY TRIAZOLO [3,4 B]BENZO[D]THIAZOLE; 7 DODECYLOXY TRIAZOLO [3,4 B]BENZO[D]THIAZOLE; 7 ETHOXYL TRIAZOLO [3,4 B]BENZO[D]THIAZOLE; 7 HEPTYLOXY TRIAZOLO[3,4 B]BENZO[D]THIAZOLE; 7 HEXYLOXY TRIAZOLO[3,4 B]BENZO[D]THIAZOLE; 7 METHOXYL TRIAZOLO[3,4 B]BENZO[D]THIAZOLE; 7 OCTYLOXY TRIAZOLO[3,4 B]BENZO[D]THIAZOLE; 7 PENTYLOXY TRIAZOLO [3,4 B]BENZO[D]THIAZOLE; 7 PROPOXY TRIAZOLO [3,4 B]BENZO[D]THIAZOLE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; TRIAZOLO [3,4 B]BENZO[D]THIAZOL 7 OL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; ELECTRIC SHOCK; GABAERGIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTICONVULSANTS; BENZOTHIAZOLES; CARBAMAZEPINE; DRUG EVALUATION, PRECLINICAL; ELECTROSHOCK; MICE; MOTOR ACTIVITY; PHENYTOIN; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 78650190945     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340610793358855     Document Type: Article

References (21)

1. Strine, T.W.; Kobau, R.; Chapman, D.P.; Thurman, D.J.; Price, P.; Balluz, L.S. Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: Results from the 2002 National Health Interview Survey. Epilepsia, 2005, 46, 1133-1139. (Pubitemid 40962160)
2. Mc Namara,O.J.; Brunton, L.L.; Lazo, J.S.; Parker, K.L., Eds.; The Pharmacological Basis of Therapeutics; McGraw-Hill: New York, 2006.
3. Kwan, P.; Brodie, M.J. Early identification of refractory epilepsy. N. Engl. J. Med., 2000, 342, 314-319. (Pubitemid 30075244)
4. Spear, B.B. Pharmacogenetics and antiepileptic drugs. Epilepsia, 2001, 42, 31-34. (Pubitemid 32947924)
5. Rémi, J.; Hüttenbrenner, A.; Feddersen, B.; Noachtar, S. Carbamazepine but not pregabalin impairs eye control: A study on acute objective CNS side effects in healthy volunteers. Epilepsy Res., 2010, 88(2-3), 145-150.
6. Meador, K.J. Newer anticonvulsants: Dosing strategies and cognition in treating patients with mood disorders and epilepsy. J. Clin. Psychiatry, 2003, 64(Suppl. 8), 30-34. (Pubitemid 36903905)
7. Belcastro, V.; Striano, P.; Gorgone, G.; Costa, C.; Ciampa, C.; Caccamo, D.; Pisani, L.R.; Oteri, G.; Marciani, M.G.; Aguglia, U.; Striano, S.; Ientile, R.; Calabresi, P.; Pisani, F. Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia, 2010, 51, 274-279.
8. Bootsma, H.P.; Ricker, L.; Hekster, Y.A.; Hulsman, J.; Lambrechts, D.; Majoie, M.; Schellekens, A.; Krom, M.; Aldenkamp, A.P. The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure, 2009, 18, 327-331.
9. Kennedy, G.M.; Lhatoo, S.D.; CNS adverse events associated with antiepileptic drugs. CNS Drugs, 2008, 22, 739-760.
10. Penovich, P.E.; Willmore, L.J.; Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy. Epilepsia, 2009, 50, 37-41.
11. Zhang, L.Q.; Guan, L.P.; Wei, C.X.; Deng, X.Q.; Quan, Z.S. Synthesis and anticonvulsant activity of some 7-alkoxy-2H-1,4- benzothiazin-3(4H)-ones and 7-alkoxy-4H-[1,2,4]triazolo[4, 3- d]benzo[b][1,4]thiazines. Chem. Pharm. Bull., 2010, 58, 326-331.
12. Achgill, R.K.; Call, L.W. Process for the preparation of tricyclagole, GB 2,027,700 A, February 27, 1980.
13. Krall, R.L.; Penry, J.K.; White, B.G.; Kupferberg, H.J.; Swinyard, E.A. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia, 1978, 19, 409-428. (Pubitemid 9016848)
14. Porter, R.J.; Cereghino, J.J.; Gladding, G.D.; Hessie, B.J.; Kupferberg, H.J.; Scoville, B.; White, B.G. Antiepileptic Drug Development Program. Cleve. Clin. Q, 1984, 51, 293-305. (Pubitemid 14038030)
15. Bernasconi, R.; Klein, M.; Martin, P.; Christen, P.; Hafner, T.; Portet, C.; Schmutz, M. Gamma-vinyl GABA: Comparison of neurochemical and anticonvulsant effects in mice. J. Neural Transm., 1988, 72, 213-233.
16. White, H.S. Preclinical development of antiepileptic drugs: Past, present, and future directions. Epilepsia, 2003, 44 (Suppl. 7), 2-8. (Pubitemid 37100022)
17. Levy, R.H.; Mattson, R.H.; Meldrum, B.S., Eds.; Raven Press: New York, 1995.
18. Okada, R.; Negishi, N.; Nagaya, H. The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazolinduced seizures. Brain Res., 1989, 480, 383-387. (Pubitemid 19050241)
19. Olsen, R.W. GABA-benzodiazepine-barbiturate receptor interactions. J. Neurochem., 1981, 37, 1-13. (Pubitemid 11088650)
20. Gale, K. GABA and epilepsy: Basic concepts from preclinical research. Epilepsia, 1992, 33 (Suppl 5), S3-S12.
21. Macdonald, R.L.; Barker, J.L. Specific antagonism of GABAmediated postsynaptic inhibition in cultured mammalian spinal cord neurons: A common mode of convulsant action. Neurology, 1978, 28, 325-330.